MELISSA MYERS: Open Payments
NPI 1073694485 · FAIRFAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$379 in 11 payments from 7 companies in 2025. Trend: 2023 $322 · 2024 $260 · 2025 $379
Food & beverage: $379
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 1 | $127 |
| Boston Scientific Corporation | 3 | $90 |
| Novartis Pharmaceuticals Corporation | 3 | $74 |
| Novo Nordisk Inc | 1 | $33 |
| SCPHARMACEUTICALS INC. | 1 | $18 |
| Amgen Inc. | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
Products named: CARDIOMEMS, LEQVIO, WATCHMAN, Wegovy, FUROSCIX, REPATHA, JARDIANCE, General - Tachy.
Industry payments across VA — which companies pay providers there.
